These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

926 related items for PubMed ID: 12757072

  • 1. The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients.
    Mootsikapun P, Chetchotisakd P, Anunnatsiri S, Choksawadphinyo K.
    J Med Assoc Thai; 2003 Apr; 86(4):293-8. PubMed ID: 12757072
    [Abstract] [Full Text] [Related]

  • 2. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
    van der Horst CM, Saag MS, Cloud GA, Hamill RJ, Graybill JR, Sobel JD, Johnson PC, Tuazon CU, Kerkering T, Moskovitz BL, Powderly WG, Dismukes WE.
    N Engl J Med; 1997 Jul 03; 337(1):15-21. PubMed ID: 9203426
    [Abstract] [Full Text] [Related]

  • 3. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group.
    Powderly WG, Saag MS, Cloud GA, Robinson P, Meyer RD, Jacobson JM, Graybill JR, Sugar AM, McAuliffe VJ, Follansbee SE.
    N Engl J Med; 1992 Mar 19; 326(12):793-8. PubMed ID: 1538722
    [Abstract] [Full Text] [Related]

  • 4. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group.
    Saag MS, Powderly WG, Cloud GA, Robinson P, Grieco MH, Sharkey PK, Thompson SE, Sugar AM, Tuazon CU, Fisher JF.
    N Engl J Med; 1992 Jan 09; 326(2):83-9. PubMed ID: 1727236
    [Abstract] [Full Text] [Related]

  • 5. Amphotericin B with or without flucytosine followed by fluconazole as primary therapy for cryptococcal meningitis in patients with AIDS.
    Jaruratanasirikul S.
    Southeast Asian J Trop Med Public Health; 1996 Dec 09; 27(4):719-23. PubMed ID: 9253873
    [Abstract] [Full Text] [Related]

  • 6. Outcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazole.
    Schaars CF, Meintjes GA, Morroni C, Post FA, Maartens G.
    BMC Infect Dis; 2006 Jul 18; 6():118. PubMed ID: 16846523
    [Abstract] [Full Text] [Related]

  • 7. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.
    Saag MS, Graybill RJ, Larsen RA, Pappas PG, Perfect JR, Powderly WG, Sobel JD, Dismukes WE.
    Clin Infect Dis; 2000 Apr 18; 30(4):710-8. PubMed ID: 10770733
    [Abstract] [Full Text] [Related]

  • 8. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
    Saag MS, Cloud GA, Graybill JR, Sobel JD, Tuazon CU, Johnson PC, Fessel WJ, Moskovitz BL, Wiesinger B, Cosmatos D, Riser L, Thomas C, Hafner R, Dismukes WE.
    Clin Infect Dis; 1999 Feb 18; 28(2):291-6. PubMed ID: 10064246
    [Abstract] [Full Text] [Related]

  • 9. Cryptococcal meningitis in patients with the acquired immunodeficiency syndrome.
    Zeind CS, Cleveland KO, Menon M, Brown JR, Solomon DK.
    Pharmacotherapy; 1996 Feb 18; 16(4):547-61. PubMed ID: 8840361
    [Abstract] [Full Text] [Related]

  • 10. Comparison of one week with two week regimens of amphotericin B both followed by fluconazole in the treatment of cryptococcal meningitis among AIDS patients.
    Tansuphaswadikul S, Maek-a-Nantawat W, Phonrat B, Boonpokbn L, Mctm AG, Pitisuttithum P.
    J Med Assoc Thai; 2006 Oct 18; 89(10):1677-85. PubMed ID: 17128844
    [Abstract] [Full Text] [Related]

  • 11. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis.
    Manosuthi W, Sungkanuparph S, Thongyen S, Chumpathat N, Eampokalap B, Thawornwan U, Foongladda S.
    J Med Assoc Thai; 2006 Jun 18; 89(6):795-802. PubMed ID: 16850679
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Maintenance therapy with itraconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome.
    Chotmongkol V, Sukeepaisarncharoen W.
    J Med Assoc Thai; 1997 Dec 18; 80(12):767-70. PubMed ID: 9470329
    [Abstract] [Full Text] [Related]

  • 14. A prospective study of AIDS-associated cryptococcal meningitis in Thailand treated with high-dose amphotericin B.
    Pitisuttithum P, Tansuphasawadikul S, Simpson AJ, Howe PA, White NJ.
    J Infect; 2001 Nov 18; 43(4):226-33. PubMed ID: 11869059
    [Abstract] [Full Text] [Related]

  • 15. Comparison of amphotericin B, flucytosine and itraconazole with amphotericin B and flucytosine in the treatment of cryptococcal meningitis in AIDS.
    Chotmongkol V, Sukeepaisarncharoen W, Thavornpitak Y.
    J Med Assoc Thai; 1997 Jul 18; 80(7):416-25. PubMed ID: 9277070
    [Abstract] [Full Text] [Related]

  • 16. Treatment of cryptococcal meningitis in Peruvian AIDS patients using amphotericin B and fluconazole.
    Dammert P, Bustamante B, Ticona E, Llanos-Cuentas A, Huaroto L, Chávez VM, Campos PE.
    J Infect; 2008 Sep 18; 57(3):260-5. PubMed ID: 18707764
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group.
    Bozzette SA, Larsen RA, Chiu J, Leal MA, Jacobsen J, Rothman P, Robinson P, Gilbert G, McCutchan JA, Tilles J.
    N Engl J Med; 1991 Feb 28; 324(9):580-4. PubMed ID: 1992319
    [Abstract] [Full Text] [Related]

  • 20. A multicentre, randomized, double-blind, placebo-controlled trial of primary cryptococcal meningitis prophylaxis in HIV-infected patients with severe immune deficiency.
    Chetchotisakd P, Sungkanuparph S, Thinkhamrop B, Mootsikapun P, Boonyaprawit P.
    HIV Med; 2004 May 28; 5(3):140-3. PubMed ID: 15139978
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.